XML 111 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Dividends declared and paid

The following table reflects the dividends paid per share within the respective three-month periods:

Fiscal Year

    

2025

    

2024

Third fiscal quarter

$

0.120

$

0.120

Second fiscal quarter

0.120

0.120

First fiscal quarter

0.120

0.120

Schedule of share repurchases

The following table summarizes all treasury stock purchases during the nine months ended March 31, 2025 and 2024 (in thousands, except per share amounts):

Nine Months Ended

March 31, 

    

2025

2024

Number of treasury shares acquired(1)

50

181

Average cost per share(1)

$

5.26

$

5.70

Total cost of treasury shares acquired

$

262

$

1,031

Schedule of Market-based Award Valuation Assumptions

For performance-based awards granted during the nine months ended March 31, 2025 and 2024, the assumptions used in the Monte Carlo simulation valuations were as follows:

Nine Months Ended

March 31, 

    

2025

    

2024

Weighted average fair value of performance-based awards granted

$

3.90

$

3.58

Risk-free interest rate

3.45%

4.87%

Expected term in years

2.78

2.77

Expected volatility

50.2%

55.0%

Dividend yield

8.4%

7.4%

Schedule of restricted stock transactions

Unvested restricted stock awards as of March 31, 2025 consisted of the following:

Weighted

Number of

Average

Restricted

Grant-Date

Award Type

    

Shares

    

Fair Value

Time-vested awards

358,977

$

6.33

Performance-based awards

417,923

5.40

Unvested at March 31, 2025

776,900

$

5.83

Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock transactions

The following table sets forth the restricted stock award transactions for the nine months ended March 31, 2025:

Weighted

Weighted

Unamortized

Average

Number of

Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

    

Shares

    

Fair Value

    

(In thousands)

    

Period (Years)

Unvested at June 30, 2024

628,511

6.31

$

2,492

1.8

Time-vested shares granted

187,155

5.70

Performance-based shares granted

189,477

4.82

Vested

(219,816)

6.22

Forfeited

(8,427)

6.05

Unvested at March 31, 2025

776,900

$

5.83

$

2,747

1.7

Contingent restricted stock grants  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock transactions

The following table sets forth contingent restricted stock unit transactions for the nine months ended March 31, 2025:

Weighted

Unamortized

Average

Number of

Weighted Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

 

    

Stock Units

    

Fair Value

    

(In thousands)

    

Period (Years)

Unvested at June 30, 2024

150,788

$

2.86

$

230

1.6

Performance-based awards granted

142,112

2.67

Forfeited

(3,394)

2.91

Unvested at March 31, 2025

289,506

$

2.77

$

412

1.9